Related Experiment Video
Updated: Jul 8, 2026
10:55
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Acute dermatomyositis associated with generalized subcutaneous edema.
Ki-Hong Lee1, Sung-Ryoun Lim, Yeon-Joo Kim
1Department of Rheumatology, Chonnam National University Medical School and Hospital, Dong-Ku, Gwangju, Republic of Korea.
Rheumatology International
|January 15, 2008
Summary
Generalized subcutaneous edema can be a rare symptom of inflammatory myopathy. This case study highlights dermatomyositis as a cause of severe edema, managed with immunosuppressive therapy.
Area of Science:
- Rheumatology
- Dermatology
- Neurology
Background:
- Inflammatory myopathies, including dermatomyositis, are rare autoimmune diseases.
- Generalized subcutaneous edema is an unusual presentation of dermatomyositis.
Observation:
- A 48-year-old female presented with severe generalized edema, skin rash, dysphagia, and proximal muscle weakness.
- Diagnostic workup included clinical examination, elevated muscle enzymes, electromyography, and muscle biopsy, confirming dermatomyositis.
- MRI showed increased signal intensity in muscle and subcutaneous tissues, ruling out other causes of edema.
Findings:
- The patient's generalized edema was determined to be secondary to dermatomyositis.
- High-dose glucocorticoids and immunosuppressive agents were initiated for treatment.
Implications:
- This case underscores the importance of considering dermatomyositis in patients with unexplained generalized edema.
- Effective management of subcutaneous edema in dermatomyositis may require aggressive immunosuppressive therapy.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...